Browsing by Author Filippatos, T.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 19 of 19
TitleAuthor(s)Issue date
Apolipoproteins C-Ii and C-Iii and Small Dense Ldl Cholesterol Levels in Non-Diabetic Obese Subjects with Metabolic SyndromeFilippatos, T.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Tzallas, C.; Bairaktari, E.; Tselepis, A.; Elisaf, M.24-Nov-2015
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteriaGazi, I.; Tsimihodimos, V.; Filippatos, T.; Bairaktari, E.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Filippatos, T.; Saougos, V.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015
The effect of hypolipidaemic agents on lipoprotein-associated phospholipase A2 (Lp-PLA2)Saougos, V.; Filippatos, T.; Kostapanos, M.; Kalogirou, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Effect of rosuvastatin on apolipoprotein CII and CIII serum levels in patients with primary dyslipidemiaKostapanos, M.; Filippatos, T.; Milionis, H.; Kostara, C.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015
Effect of rosuvastatin on low density lipoprotein (LDL) concentration and relative distribution in patients with primary dyslipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Milionis, H.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Effect of rosuvastatin on low density lipoprotein (LDL) profile in patients with primary dyslipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Saougos, V. G.; Milionis, H. J.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
The Effects of Ezetimibe and Orlistat, Alone or in Combination, on High Density Lipoprotein (Hdl) Subclasses and Hdl-Associated Enzyme Activities in Overweight and Obese Patients with HyperlipidaemiaNakou, E.; Filippatos, T.; Kiortsis, D.; Derdemezis, C.; Georgoula, M.; Petraki, M.; Tselepis, A.; Elisaf, M.24-Nov-2015
The Effects of Ezetimibe, Alone or Combined with Orlistat, on Triglyceride-Rich Lipoprotein Metabolism in Overweight and Obese Patients with HyperlipidaemiaNakou, E.; Filippatos, T.; Kostara, C.; Agouridis, A.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015
Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot studyDerdemezis, C.; Filippatos, T.; Tselepis, A.; Mikhailidis, D.; Elisaf, M. S.24-Nov-2015
Effects of rosuvastatin on serum homocysteine, vitamin B12 and folic acid levels in patients with primary hyperlipidemiaChasiotis, G.; Milionis, H.; Gazi, I.; Filippatos, T.; Bairaktari, E.; Elisaf, M. S.; Seferiadis, K.24-Nov-2015
High-Density Lipoprotein Subclasses in Patients with or without the Metabolic SyndromeLagos, K. G.; Gazi, I. F.; Kostapanos, M. S.; Filippatos, T.; Kazakou, P. S.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
LDL subfractions in patients with metabolic syndromeGazi, I.; Filippatos, T.; Bairaktari, E.; Kostara, C.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Lipoprotein-associated phospholipase A(2) activity is a marker of small, dense LDL particles in human plasmaGazi, I.; Lourida, E. S.; Filippatos, T.; Tsimihodimos, V.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particlesGazi, I.; Lourida, E.; Filippatos, T.; Tsimihodimos, V.; Saougos, V.; Elisaf, M.; Tselepis, A.24-Nov-2015
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic ProfileFilippatos, T.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Rosuvastatin administration decreases apolipoprotein CII and CIII serum levels in patients with primary dysilipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Saougos, V. G.; Milionis, H. J.; Kostara, C.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015
Treatment of hyperlipidaemia with fenofibrate and related fibratesFilippatos, T.; Milionis, H. J.24-Nov-2015